Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.


NVAX data by YCharts

Image placeholder title

Novavax (NVAX) - Get Report : In an exclusive interview, Cramer checked in with Stanley Erck, president and CEO of vaccine maker Novavax, a stock that was trading at $13.65 a share when Cramer last sat down with Erck on Aug. 12, but has since fallen a stunning 53%.

Erck said his team was not focused on the stock price but executing the five clinical trials to be completed by the third quarter of this year. He said those trials include vaccines for Ebola, flu and RSV, a far-too-common respiratory virus.

Erck was happy to report positive results from the RSV trial for the elderly, which contract the disease some 2.4 million times a year, and also for new mothers and their newborns. Some 60% of all infections during a newborn's first year stem from RSV, Erck noted, making it a serious issue worldwide.

The RSV results were so positive that Novavax just received an $89 million grant from the Bill and Melinda Gates Foundation to continue development of the vaccine and help make it available globally.

Cramer said it's clear the decline in Novavax stock has nothing to do with the company and its remarkable progress.


XOM data by YCharts

Image placeholder title

Exxon Mobil (XOM) - Get Report : Cramer went "Off the Charts" with colleague Robert Moreno over the chart of Exxon to see if the oil patch may finally be forming a much-needed bottom.

Looking at a daily chart of Exxon versus the S&P 500, Moreno noted the oil giant was leading the averages lower until about a month ago, when it began consolidating and trading sideways. He saw support building at the $71.75 level, which Cramer noted is about where the stock yields 4%.

This bottoming pattern was bolstered by both the MACD momentum indicator, which has been trending higher, and the AROON indicator, which is a measure of changes in trend. The AROON correctly predicted the bullish move in Exxon this spring, as well as the bearish move in May, and just last week signaled another uptrend.

Moreno also noted the Chaikin Money Flow, or CMF, has also been trending higher for the past month.

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.